TYLER BERENJI: Open Payments
NPI 1194106914 · SALINAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,995 in 86 payments from 20 companies in 2025. Trend: 2023 $2,521 · 2024 $2,385 · 2025 $1,995
Food & beverage: $1,845Consulting: $150
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 6 | $332 |
| Merck Sharp & Dohme LLC | 11 | $274 |
| Novartis Pharmaceuticals Corporation | 13 | $261 |
| E.R. Squibb & Sons, L.L.C. | 7 | $190 |
| PFIZER INC. | 12 | $163 |
| Amgen Inc. | 9 | $148 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $114 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $101 |
| Novo Nordisk Inc | 3 | $52 |
| Edwards Lifesciences Corporation | 1 | $50 |
Products named: LEQVIO, VERQUVO, ELIQUIS, CONFIRM RX, REPATHA, Kerendia, ACCENT, JARDIANCE.
Industry payments across CA — which companies pay providers there.
